๐Ÿ‡บ๐Ÿ‡ธ US Earnings by TNBfolio
5.8K subscribers
49.2K photos
44.7K links
Download Telegram
#CECO

CECO Environmental's Q2 Non-GAAP Earnings, Revenue Increase; Raises 2024 Revenue Guidance
https://finance.yahoo.com/news/ceco-environmental-apos-q2-non-132804519.html

CECO Environmental (CECO) Surpasses Q2 Earnings Estimates
https://finance.yahoo.com/news/ceco-environmental-ceco-surpasses-q2-121506474.html

CECO: Q2 Earnings Snapshot
https://finance.yahoo.com/news/ceco-q2-earnings-snapshot-111136580.html

CECO Environmental Reports Second Quarter 2024 Results
https://finance.yahoo.com/news/ceco-environmental-reports-second-quarter-110000858.html

Tetra Tech (TTEK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
https://finance.yahoo.com/news/tetra-tech-ttek-earnings-expected-140129191.html
Nautilus Biotechnology, Inc. (NAUT)
์‹œ๊ฐ€์ด์•ก: 343.23M
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Biotechnology_Laboratory_Analytical_Instruments
์„นํ„ฐ: #Industrials
ํ™ˆํŽ˜์ด์ง€: https://www.nautilus.bio

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 0.00 / -- / -- / -- / --
2403: 0.0 / -- / -- / -- / --
2312: 0.0 / -- / -- / -- / --
2309: 0.0 / -- / -- / -- / --
2306: 0.0 / -- / -- / -- / --

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: -0.14 / -0.16 / 12.5% / -7.7% / 6.7%
2403: -0.15 / -- / -- / -25.0% / --
2312: -- / -- / -- / -- / --
2309: -0.13 / -- / -- / -- / 0.0%
2306: -0.13 / -- / -- / -- / -8.3%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 0.0(--) / --(--)
2212: 0.0(--) / -0.46(23.3%)
2112: 0.0(--) / -0.6(-376.5%)
2012: 0.0(--) / -0.125914(--)

#NAUT

- ์‚ฌ์—…์š”์•ฝ: Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. The company develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instru...
Leonardo DRS, Inc. (DRS)
์‹œ๊ฐ€์ด์•ก: 7.74B
๊ตญ๊ฐ€: Israel
์‚ฐ์—…: #Industrial_Machinery_Components
์„นํ„ฐ: #Industrials
ํ™ˆํŽ˜์ด์ง€: https://www.leonardodrs.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 753M / 671.83M / 12.1% / 19.9% / 9.4%
2403: 688.0M / -- / -- / 20.9% / -25.7%
2312: 926.0M / -- / -- / -- / 31.7%
2309: 703.0M / -- / -- / -- / 11.9%
2306: 628.0M / -- / -- / -- / 10.4%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 0.18 / 0.16 / 12.5% / 38.5% / 63.6%
2403: 0.11 / -- / -- / 120.0% / -60.7%
2312: 0.28 / -- / -- / -- / 55.6%
2309: 0.18 / -- / -- / -- / 38.5%
2306: 0.13 / -- / -- / -- / 160.0%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 2.83B(4.9%) / 0.64(-66.0%)
2212: 2.69B(-6.5%) / 1.88(157.5%)
2112: 2.88B(3.6%) / 0.73(24.5%)
2012: 2.78B(--) / 0.586207(--)

#DRS

- ์‚ฌ์—…์š”์•ฝ: Leonardo DRS, Inc., together with its subsidiaries, provides defense electronic products and systems, and military support services. It operates through Advanced Sensing and Computing (ASC) segment, and Integrated Mission Systems (IMS) segments. The ASC segmen...
Day One Biopharmaceuticals, Inc. (DAWN)
์‹œ๊ฐ€์ด์•ก: 1.35B
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Biotechnology_Pharmaceutical_Preparations
์„นํ„ฐ: #Health_Care
ํ™ˆํŽ˜์ด์ง€: https://dayonebio.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 8.19M / 1.02M / 702.9% / -- / --
2403: 0.0 / -- / -- / -- / --
2312: 0.0 / -- / -- / -- / --
2309: 0.0 / -- / -- / -- / --
2306: 0.0 / -- / -- / -- / --

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: -0.05 / -0.67 / 92.5% / 91.8% / 93.1%
2403: -0.72 / -- / -- / -22.0% / --
2312: -- / -- / -- / -- / --
2309: -0.54 / -- / -- / -- / 11.5%
2306: -0.61 / -- / -- / -- / -3.4%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 0.0(--) / --(--)
2212: 0.0(--) / -2.17(53.0%)
2112: 0.0(--) / -4.62(-379.4%)
2012: 0.0(--) / -0.963742(-220.6%)

#DAWN

- ์‚ฌ์—…์š”์•ฝ: Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma...
#DAWN

Day One Biopharmaceuticals Q2 Net Loss Narrows
https://finance.yahoo.com/news/day-one-biopharmaceuticals-q2-net-133138714.html

Day One Biopharmaceuticals, Inc. (DAWN) Reports Q2 Loss, Tops Revenue Estimates
https://finance.yahoo.com/news/day-one-biopharmaceuticals-inc-dawn-124005581.html

Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
https://finance.yahoo.com/news/day-one-reports-second-quarter-113000638.html

Day One Announces Oversubscribed $175.0 Million Private Placement
https://finance.yahoo.com/news/day-one-announces-oversubscribed-175-110000083.html

Ipsen outlines $461m for ex-US rights to Day Oneโ€™s glioma therapy
https://finance.yahoo.com/m/43cfb996-e9aa-314e-ba6d-da4d68242c87/ipsen-outlines-%24461m-for.html
Microsoft Corporation (MSFT)
์‹œ๊ฐ€์ด์•ก: 3.15T
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Computer_Software_Prepackaged_Software
์„นํ„ฐ: #Technology
ํ™ˆํŽ˜์ด์ง€: https://www.microsoft.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 64.7B / 64.38B / 0.5% / 15.1% / 4.6%
2403: 61.86B / -- / -- / 17.0% / -0.3%
2312: 62.02B / -- / -- / -- / 9.7%
2309: 56.52B / -- / -- / -- / 0.6%
2306: 56.19B / -- / -- / -- / 6.3%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 2.95 / 2.94 / 0.3% / 9.7% / 0.3%
2403: 2.94 / -- / -- / 20.0% / 0.3%
2312: 2.93 / -- / -- / -- / -2.0%
2309: 2.99 / -- / -- / -- / 11.2%
2306: 2.69 / -- / -- / -- / 9.8%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2306: 211.91B(6.9%) / 9.68(0.3%)
2206: 198.27B(18.0%) / 9.65(19.9%)
2106: 168.09B(17.5%) / 8.05(39.8%)
2006: 143.01B(--) / 5.76(--)

#MSFT

- ์‚ฌ์—…์š”์•ฝ: Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and ...
Arista Networks, Inc. (ANET)
์‹œ๊ฐ€์ด์•ก: 97.43B
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Computer_Communications_Equipment
์„นํ„ฐ: #Telecommunications
ํ™ˆํŽ˜์ด์ง€: https://www.arista.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 1.69B / 1.65B / 2.4% / 15.8% / 7.5%
2403: 1.57B / -- / -- / 16.3% / 2.0%
2312: 1.54B / -- / -- / -- / 2.1%
2309: 1.51B / -- / -- / -- / 3.5%
2306: 1.46B / -- / -- / -- / 8.0%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 2.1 / 1.94 / 8.2% / 35.5% / 5.5%
2403: 1.99 / -- / -- / 44.2% / 3.6%
2312: 1.92 / -- / -- / -- / 11.6%
2309: 1.72 / -- / -- / -- / 11.0%
2306: 1.55 / -- / -- / -- / 12.3%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 5.86B(33.8%) / --(--)
2212: 4.38B(48.6%) / 4.27(62.4%)
2112: 2.95B(27.2%) / 2.63(31.5%)
2012: 2.32B(--) / 2.0(-24.8%)

#ANET

- ์‚ฌ์—…์š”์•ฝ: Arista Networks, Inc. engages in the development, marketing, and sale of data-driven, client to cloud networking solutions for data center, campus, and routing environments in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. Its cloud networking s...
Mondelez International, Inc. (MDLZ)
์‹œ๊ฐ€์ด์•ก: 89.98B
๊ตญ๊ฐ€: United States
์‚ฐ์—…: #Packaged_Foods
์„นํ„ฐ: #Consumer_Staples
ํ™ˆํŽ˜์ด์ง€: https://www.mondelezinternational.com

- ๋ถ„๊ธฐ ๋งค์ถœ(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 8.34B / 8.45B / -1.3% / -2.0% / -10.2%
2403: 9.29B / -- / -- / 1.4% / -0.3%
2312: 9.31B / -- / -- / -- / 3.2%
2309: 9.03B / -- / -- / -- / 6.1%
2306: 8.51B / -- / -- / -- / -7.2%

- ๋ถ„๊ธฐ EPS(๊ณต์‹œ, ์˜ˆ์ธก, ์„œํ”„, YoY, MoM)
2406: 0.86 / 0.79 / 8.9% / 24.6% / -17.3%
2403: 1.04 / -- / -- / -31.6% / 48.6%
2312: 0.7 / -- / -- / -- / -2.8%
2309: 0.72 / -- / -- / -- / 4.3%
2306: 0.69 / -- / -- / -- / -54.6%

- ์—ฐ๊ฐ„ ๋งค์ถœ(YoY%), EPS(YoY%)
2312: 36.02B(14.4%) / 3.62(84.7%)
2212: 31.5B(9.7%) / 1.96(-35.5%)
2112: 28.72B(8.0%) / 3.04(23.1%)
2012: 26.58B(--) / 2.47(--)

#MDLZ

- ์‚ฌ์—…์š”์•ฝ: Mondelez International, Inc., through its subsidiaries, manufactures, markets, and sells snack food and beverage products in the Latin America, North America, Asia, the Middle East, Africa, and Europe. It provides biscuits and baked snacks, including coo...